MedVi vs HumeCare+: Price, meds, and support compared
MedVi vs HumeCare+ answers a straightforward question: choose MedVi if you want the lowest promotional price and a no-clinic telehealth route; choose HumeCare+ if you want a bundled protocol with body composition tracking and a money-back promise. Early verdict: MedVi is the entry-level, lower-first-month cost option; HumeCare+ is the protocol-focused option with added supplements, scans, and a refund commitment.
Pricing and promotional structure
MedVi advertises compounded semaglutide starting at $179/month as a winter promotional first month, including fast, free shipping, with ongoing standalone months rising to $299 and a three-month plan at $649. HumeCare+ lists semaglutide from $199/mo and a dual-action tirzepatide protocol from $299/mo, with the site noting those prices reflect a promotional discount that may change. Both operate on a cash-pay model for compounded medications; neither offers branded FDA-approved medication prices in the supplied evidence.
Medication choices and clinical approach
MedVi offers clinically dosed compounded semaglutide only, with provider review and telehealth-based prescribing. HumeCare+ offers a choice between personalized compounded semaglutide or dual-action tirzepatide, with the dose set by your provider. If having tirzepatide available is important, HumeCare+ supports that option; if you prefer a semaglutide-only pathway and the lowest first-month outlay, MedVi is positioned around that use case.
Support, protocol extras, and monitoring
MedVi emphasizes a simple online process, no clinic visits, and 24/7 support from certified medical professionals. HumeCare+ wraps clinician-prescribed GLP-1 medication with glycine, vitamin B12 and B6 included in the protocol, monthly body composition scans to track fat versus lean mass, an app for tracking, and unlimited clinician access. HumeCare+ describes these extras as addressing muscle loss and side effects that bare GLP-1 programs ignore. These represent a core philosophical difference: MedVi prioritizes simplicity and lower promo cost; HumeCare+ prioritizes a bundled, muscle-preserving protocol and monitoring.
See MedVi plan details and 24/7 support
Refunds, cancellation, and delivery
HumeCare+ advertises a 10%-or-your-money-back promise over six months, subject to full terms and eligibility. HumeCare+ also notes cancel subscription anytime and free next-day delivery. MedVi describes fast, free shipping for the first month promo and a program that starts with no contract; MedVi also notes that OpenLoop Health clinicians retain prescription decisions and that the assessment does not create a doctor patient relationship. Both providers state medication is included in their program cost when applicable.
Regulatory and safety notes
Both vendors offer compounded medications. The supplied evidence for MedVi and HumeCare+ states that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. MedVi materials emphasize that compounded GLP-1s are produced in FDA-regulated facilities but are not FDA-approved or evaluated for safety or efficacy. HumeCare+ highlights similar regulatory language and adds that GLP-1 drugs carry serious risks, including a boxed warning for thyroid C-cell tumors. Both emphasize clinician discretion: prescriptions are provided only when a licensed clinician determines it is medically appropriate.
Side by side comparison table
| Criteria | MedVi | HumeCare+ |
|---|---|---|
| Starting price | $179 first-month promo | Semaglutide from $199/mo; tirzepatide from $299/mo |
| Medication options | Compounded semaglutide only | Compounded semaglutide or tirzepatide |
| Support model | 24/7 certified medical support, no clinic visits | 24/7 clinician access, app, monthly scans |
| Protocol extras | Simple online intake, physician review | Glycine plus B6 and B12, body composition scans |
| Refund / guarantee | No published refund guarantee in supplied evidence | 10%-or-money-back promise over six months, terms apply |
| Regulatory note | Compounded meds not FDA-approved | Compounded meds not FDA-evaluated; GLP-1 risks noted |
Explore HumeCare+ protocols and scans
How results and expectations are presented
MedVi cites self-reported patient data and notes typical MedVi patients may see 1 to 2 lbs per week after 4 weeks with diet and exercise, while also cautioning results vary. HumeCare+ shares internal, company-reported headline results and specifies that individual results may vary; it also states it can take up to 8 to 9 weeks to feel full effects and that weight loss timelines range across months. Where outcome claims appear, both vendors preserve qualifiers and note variability.
Compare MedVi program inclusions
Final thoughts on MedVi vs HumeCare+
MedVi vs HumeCare+ boils down to tradeoffs: MedVi offers the lower promotional entry price, a fully online no-clinic workflow, and round the clock certified support for compounded semaglutide. HumeCare+ bundles clinician-prescribed GLP-1 medication with supportive ingredients, body composition scans, an app, and a stated 10%-or-money-back promise over six months. Use the primary keyword as a reminder: MedVi vs HumeCare+ highlights price and simplicity versus protocol depth and tracking.
Choose MedVi if you want the simplest online path to compounded semaglutide with a $179 promotional first month, fast free shipping, and 24/7 certified medical support.
Choose HumeCare+ if you want a bundled protocol with glycine and B vitamins, monthly body composition scans, the option of tirzepatide, and a 10%-or-your-money-back promise over six months, subject to terms.